RELYVRIO
Live / Registered — Registered (as of 07 Feb 2023)
What this means for you
Registered since 07 Feb 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90544439
- Registration number
- 6975321
- Mark type
- Stylized text
- Filed
- 24 Feb 2021
- Published for opposition
- 26 Oct 2021
- Registered
- 07 Feb 2023
- Attorney of record
- Cynthia Johnson Walden
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of neurological diseases and neurodegenerative diseases
Owner
- Amylyx Pharmaceuticals, Inc., Cambridge, MA, US
- Amylyx Pharmaceuticals, Inc., Cambridge, MA, US
- Amylyx Pharmaceuticals, Inc., Cambridge, MA, US
Prosecution history
- 23 Feb 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 23 Feb 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 23 Feb 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 23 Feb 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 23 Feb 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 07 Feb 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 07 Feb 2023 — REGISTERED-PRINCIPAL REGISTER
- 06 Jan 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Jan 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 05 Jan 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 05 Jan 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 30 Nov 2022 — USE AMENDMENT FILED
- 05 Jan 2023 — SOU EXTENSION 1 GRANTED
- 14 Dec 2022 — SOU EXTENSION 1 FILED
- 04 Jan 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL